Artikler med mandater om offentlig tilgang - Rebecca FitzgeraldLes mer
TotaltCancer Research UKMRCNIHRNIHWellcomeEuropean CommissionNHMRCUK Research & InnovationEPSRCRoyal Society UKGatesARCHRBVersus Arthritis, UKGovernment of SpainCPRITSNSFCIHRDFGCZINSFHHMIGenome CanadaNSFCDFFFCTBBSRCBHFYorkshire Cancer Research, UKZonMwBMBFWorld Cancer Researh Fund, UKFAPESPVAAHANSERCEMBLAcademy of FinlandHEASwedish Research CouncilKNAWKWFNMRCMichael J Fox FoundationAIRC Foundation for Cancer Research in ItalyPancreatic Cancer, UKHealth Data Research, UKOICRHealth and Care Research Wales
Ikke tilgjengelige noe sted: 27
The future of early cancer detection
RC Fitzgerald, AC Antoniou, L Fruk, N Rosenfeld
Nature medicine 28 (4), 666-677, 2022
Mandater: Cancer Research UK
Extensive phylogenies of human development inferred from somatic mutations
THH Coorens, L Moore, PS Robinson, R Sanghvi, J Christopher, ...
Nature 597 (7876), 387-392, 2021
Mandater: Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
A review of the current understanding and clinical utility of miRNAs in esophageal cancer
NS Sakai, E Samia-Aly, M Barbera, RC Fitzgerald
Seminars in cancer biology 23 (6), 512-521, 2013
Mandater: UK Medical Research Council
An Overview of Helicobacter pylori Infection
R FitzGerald, SM Smith
Helicobacter pylori, 1-14, 2021
Mandater: Health Research Board, Ireland
Genetic predisposition to gastro-oesophageal cancer
P Lao-Sirieix, C Caldas, RC Fitzgerald
Current opinion in genetics & development 20 (3), 210-217, 2010
Mandater: Cancer Research UK
Evolution and progression of Barrett’s oesophagus to oesophageal cancer
S Killcoyne, RC Fitzgerald
Nature Reviews Cancer 21 (11), 731-741, 2021
Mandater: Cancer Research UK, UK Medical Research Council
Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis
AL Paterson, M O'Donovan, E Provenzano, LJ Murray, HG Coleman, ...
The Journal of pathology 230 (1), 118-128, 2013
Mandater: UK Medical Research Council
The'–omics' revolution and oesophageal adenocarcinoma
JMJ Weaver, CS Ross-Innes, RC Fitzgerald
Nature reviews Gastroenterology & hepatology 11 (1), 19-27, 2014
Mandater: UK Medical Research Council
Molecular markers for Barrett's esophagus and its progression to cancer
DRF Elliott, RC Fitzgerald
Current Opinion in Gastroenterology 29 (4), 437-445, 2013
Mandater: Cancer Research UK, UK Medical Research Council
Generation and validation of a revised classification for oesophageal and junctional adenocarcinoma
CJ Peters, RH Hardwick, SL Vowler, RC Fitzgerald
Journal of British Surgery 96 (7), 724-733, 2009
Mandater: Cancer Research UK
Endoscopic TriModal imaging and biomarkers for neoplasia conjoined: a feasibility study in Barrett’s esophagus
DF Boerwinkel, M Di Pietro, X Liu, MK Shariff, P Lao-Sirieix, CE Walker, ...
Diseases of the Esophagus 27 (5), 435-443, 2014
Mandater: UK Medical Research Council
Biomarkers in Barrett’s esophagus: role in diagnosis, risk stratification, and prediction of response to therapy
A Bansal, RC Fitzgerald
Gastroenterology Clinics 44 (2), 373-390, 2015
Mandater: UK Medical Research Council
Fluorescence imaging for the detection of early neoplasia in Barrett’s esophagus: old looks or new vision?
DF Boerwinkel, MK Shariff, M di Pietro, JA Holz, MC Aalders, WL Curvers, ...
European Journal of Gastroenterology & Hepatology 26 (7), 691-698, 2014
Mandater: UK Medical Research Council, National Institute for Health Research, UK
Pathologic lymph node regression after neoadjuvant chemotherapy predicts recurrence and survival in esophageal adenocarcinoma: a multicenter study in the United Kingdom
JL Moore, M Green, A Santaolalla, H Deere, RPT Evans, M Elshafie, ...
Journal of Clinical Oncology 41 (28), 4522-4534, 2023
Mandater: Cancer Research UK
Hereditary diffuse gastric cancer: approaches to screening, surveillance, and treatment
ND Pilonis, M Tischkowitz, RC Fitzgerald, M di Pietro
Annual Review of Medicine 72 (1), 263-280, 2021
Mandater: Cancer Research UK, UK Medical Research Council
The use of molecular markers in predicting dysplasia and guiding treatment
S Zeki, RC Fitzgerald
Best practice & research Clinical gastroenterology 29 (1), 113-124, 2015
Mandater: UK Medical Research Council
GWAS meta-analysis of 16 790 patients with Barrett’s oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease …
J Schröder, L Chegwidden, C Maj, J Gehlen, J Speller, AC Böhmer, ...
Gut 72 (4), 612-623, 2023
Mandater: German Research Foundation, Cancer Research UK, UK Medical Research Council …
Biomarkers for dysplastic Barrett’s: ready for prime time?
EM Gregson, RC Fitzgerald
World journal of surgery 39, 568-577, 2015
Mandater: UK Medical Research Council, National Institute for Health Research, UK
Genomic instability signals offer diagnostic possibility in early cancer detection
S Killcoyne, A Yusuf, RC Fitzgerald
Trends in Genetics 37 (11), 966-972, 2021
Mandater: UK Medical Research Council
Shared genetic etiology of obesity-related traits and Barrett's esophagus/adenocarcinoma: insights from genome-wide association studies
AC Böhmer, J Hecker, J Schröder, P Gharahkhani, A May, C Gerges, ...
Cancer Epidemiology, Biomarkers & Prevention 29 (2), 427-433, 2020
Mandater: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Informasjon om publisering og finansiering fastsettes automatisk av et datamaskinprogram